PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann(Vanderbilt University), Jennifer A. Pietenpol(Vanderbilt University)
Cited by 331
Related Papers
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
|Nature Communications|2021|255
Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest
|Journal of Biological Chemistry|1998|230
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
|BMC Cancer|2017|54
Tissue-specific expression of p73 and p63 isoforms in human tissues
|Cell Death and Disease|2021|27